Biosergen AB (BIOSGN.ST)
SEK 0.51
(-5.9%)
SEK 0.51
(-5.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | 8.57 Million | 4.43 Million | 1.31 Million |
| Cost of Revenue | 456 Thousand | 280 Thousand | 178 Thousand | 10.52 Million | - |
| Gross Profit | -456 Thousand | -280 Thousand | 8.39 Million | -6.09 Million | 1.31 Million |
| Operating Expenses | 26.8 Million | 33.84 Million | 33.9 Million | 6.22 Million | 6.51 Million |
| Selling, General and Administrative Expenses | 34.31 Million | 38.56 Million | 40.64 Million | 10.52 Million | 2.82 Million |
| Research and Development Expenses | - | - | - | 10.99 Million | 3.69 Million |
| Other Expenses | -7.5 Million | 33.84 Million | -6.74 Million | -4.3 Million | - |
| Cost and Expenses | 27.26 Million | 34.12 Million | 34.07 Million | 6.22 Million | 6.51 Million |
| Operating Income | -27.26 Million | -34.12 Million | -34.07 Million | -6.22 Million | -6.51 Million |
| Interest Expense | - | 54 Thousand | 240 Thousand | - | 76.35 Thousand |
| Income Tax Expense | - | -135 Thousand | 240 Thousand | 498 Thousand | -5156.81 |
| Earnings before Tax | -27.03 Million | -34.04 Million | -34.31 Million | -6.72 Million | -5.42 Million |
| Net Income | -27.03 Million | -33.91 Million | -34.55 Million | -7.22 Million | -5.42 Million |
| Earnings Per Share Basic | -0.60 | -0.64 | -0.65 | -0.03 | -0.03 |
| Earnings Per Share Diluted | -0.60 | -0.64 | -0.65 | -0.03 | -0.03 |
| Weighted Average Shares Outstanding | 44.92 Million | 52.76 Million | 53.48 Million | 207.24 Million | 207.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.92 Million | 52.76 Million | 53.48 Million | 207.24 Million | 207.24 Million |
| Gross Margin | - | - | 0.98 | -1.38 | 1.00 |
| EBIT Margin | - | - | -3.98 | -1.40 | -4.96 |
| Profit Margin | - | - | -4.03 | -1.63 | -4.12 |
| EBITDA | 228 Thousand | -39.98 Million | - | -6.72 Million | -187.98 Thousand |
| Earnings Before Tax Margin | - | - | -3.98 | -1.40 | -4.96 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | 224 Thousand | 456 Thousand | 2000.00 | 10 Thousand |
| Gross Profit | - | - | -224 Thousand | -456 Thousand | -2000.00 | -10 Thousand |
| Operating Expenses | 5.72 Million | 6.79 Million | 6.62 Million | 34.77 Million | 7.53 Million | 8.02 Million |
| Selling, General and Administrative Expenses | 6.33 Million | 7.34 Million | 6.62 Million | - | 7.94 Million | 10.33 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -604 Thousand | - | - | - | - | - |
| Cost and Expenses | 5.72 Million | 6.79 Million | 6.62 Million | 34.77 Million | 7.53 Million | 8.03 Million |
| Operating Income | -5.72 Million | -6.79 Million | -6.62 Million | -34.77 Million | -7.53 Million | -8.03 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -43.27 Thousand | 6.61 Million | 34.74 Million | -7537.00 | -122.08 Thousand |
| Earnings before Tax | -5.72 Million | -6.89 Million | -6.46 Million | -27.03 Million | -7.51 Million | -8.03 Million |
| Net Income | -5.72 Million | -6.89 Million | -6.46 Million | -27.03 Million | -7.51 Million | -8.03 Million |
| Earnings Per Share Basic | -0.04 | -0.14 | -0.08 | - | -0.10 | -0.11 |
| Earnings Per Share Diluted | -0.04 | -0.14 | -0.08 | - | -0.10 | -0.11 |
| Weighted Average Shares Outstanding | 143.2 Million | 50.68 Million | 85.72 Million | 75.98 Million | 75.85 Million | 71.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 143.2 Million | 50.68 Million | 85.72 Million | 75.98 Million | 75.85 Million | 71.76 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -5.72 Million | -6.79 Million | -6.42 Million | - | -7.53 Million | -8.03 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
3073
ANZLY
EBO
600845
NIVF
WWL